Samsung Biologics to issue new shares worth $1.1 billion ahead of IPO
 

Samsung Biologics to issue new shares worth $1.1 billion ahead of IPO
SEOUL (Reuters) - South Korean drugmaker Samsung Biologics Co plans to issue about 1.23 trillion won ($1.12 billion) of new shares as it lines up an initial public offering, its biggest shareholder...http://feeds.feedburner.com/~ff/news...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/news...tA:V_sGLiPBpWU http://feeds.feedburner.com/~ff/news...tA:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/news/...~4/LOesUNecTwg